Affordable Access

deepdyve-link
Publisher Website

Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?

Authors
  • Patel, S1
  • Kostaras, X2
  • Parliament, M1
  • Olivotto, I A3
  • Nordal, R3
  • Aronyk, K4
  • Hagen, N2
  • 1 Department of Radiation Oncology, Cross Cancer Institute, and Department of Oncology, University of Alberta, Edmonton, AB.
  • 2 Guideline Utilization Resource Unit, Alberta Health Services, Calgary, AB.
  • 3 Division of Radiation Oncology, Tom Baker Cancer Centre, and University of Calgary, Calgary, AB.
  • 4 Division of Neurosurgery, University of Alberta, Edmonton, AB.
Type
Published Article
Journal
Current oncology (Toronto, Ont.)
Publication Date
Oct 01, 2014
Volume
21
Issue
5
Pages
251–262
Identifiers
DOI: 10.3747/co.21.2207
PMID: 25302033
Source
Medline
Keywords
License
Unknown

Abstract

Referral for pbt is recommended for patients who are being treated with curative intent and with an expectation for long-term survival, and who are able and willing to travel abroad to a proton facility. Commonly accepted indications for referral include chordoma and chondrosarcoma, intraocular melanoma, and solid tumours in children and adolescents who have the greatest risk for long-term sequelae. Current data do not provide sufficient evidence to recommend routine referral of patients with most head-and-neck, breast, lung, gastrointestinal tract, and pelvic cancers, including prostate cancer. It is recommended that all referrals be considered by a multidisciplinary team to select appropriate cases.

Report this publication

Statistics

Seen <100 times